| Kevin Ali | Former Chief Executive Officer | FY2025 | |
| Joseph Morrissey | Interim Chief Executive Officer | FY2025 | |
| Matthew Walsh | EVP and Chief Financial Officer | FY2025 | |
| Juan Camilo Arjona Ferreira, M.D. | EVP and Head of R&D and Chief Medical Officer | FY2025 | |
| Rachel Stahler | EVP and Chief Digital & Growth Officer | FY2025 | |
| Kirke Weaver | EVP, General Counsel and Corporate Secretary | FY2025 |
6 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.